Sharechat Logo

General Capital Limited (NZX: GEN) Subsidiary IRG Makes Strong Progress

Friday 29th January 2021

Text too small?

General Capital, the listed financial services Group, today updated the market as follows:

Mr. Brent King, Managing Director of General Capital advises that wholly owned subsidiary, Investment Research Group Limited (IRG), has made solid progress over the last two months.

- IRG has completed the 46th Edition of the IRG Yearbook and copies are available online or through good bookstores. The IRG Yearbook has a proud history of providing research to investors.

- IRG is in the process of preparing a listing application for Greenfern Industries Limited (Greenfern), a multi-product Medical Cannabis and Hemp business. Greenfern and IRG are in the process of appointing various advisors and directors. The application is expected to be completed within two months.

Mr. King said, “No decision has been made regarding the most appropriate exchange on which to seek a listing. No discussions have been held with the ASX or the NZX. Further announcements will be made as progress is made.”

Please see the link below for more details:

General Capital (GEN) subsidiary IRG makes strong progress

Source: General Capital Limited



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Meridian Energy monthly operating report for July 2022
Cannasouth to launch a pro-rata renounceable rights issue
August 12th Morning Report
2022 Annual Shareholders' Meeting & Director Nominations
Rakon 2022 Annual Meeting Chair's Address and Presentation
VHP - Full year results release
RAKON FY23 Earnings Guidance
August 11th Morning Report
Deferral of FDA consideration of enforcement discretion
MHJ - Response to ASX Query